Targeting of the class II transactivator attenuates inflammation and neurodegeneration in an alpha-synuclein model of Parkinson's disease.

Williams GP, Schonhoff AM, Jurkuvenaite A, Thome AD, Standaert DG, Harms AS
J Neuroinflammation. 2018 Aug 30;15(1):244. doi: 10.1186/s12974-018-1286-2. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.